{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:04:47Z","timestamp":1785542687169,"version":"3.56.0"},"reference-count":162,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":2385,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jpain.2016.10.020","type":"journal-article","created":{"date-parts":[[2016,11,21]],"date-time":"2016-11-21T07:47:50Z","timestamp":1479714470000},"page":"233-246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["AAPT Diagnostic Criteria for Chronic Cancer Pain Conditions"],"prefix":"10.1016","volume":"18","author":[{"given":"Judith A.","family":"Paice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6357-3848","authenticated-orcid":false,"given":"Matt","family":"Mulvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Dougherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8656-5157","authenticated-orcid":false,"given":"John T.","family":"Farrar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick W.","family":"Mantyh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Miaskowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpain.2016.10.020_bib1","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1186\/s12885-015-1418-3","article-title":"Impact of cancer and chemotherapy on autonomic nervous system function and cardiovascular reactivity in young adults with cancer: A case-controlled feasibility study","volume":"15","author":"Adams","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jpain.2016.10.020_bib2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mdt409","article-title":"Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: Two sides of the same coin","volume":"25","author":"Alberti","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jpain.2016.10.020_bib3","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3109\/0284186X.2012.692884","article-title":"Persistent pain, sensory disturbances and functional impairment after adjuvant chemotherapy for breast cancer: Cyclophosphamide, epirubicin and fluorouracil compared with docetaxel + epirubicin and cyclophosphamide","volume":"51","author":"Andersen","year":"2012","journal-title":"Acta Oncol"},{"key":"10.1016\/j.jpain.2016.10.020_bib4","first-page":"CD007519","article-title":"Celiac plexus block for pancreatic cancer pain in adults","author":"Arcidiacono Paolo","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpain.2016.10.020_bib5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.critrevonc.2011.04.012","article-title":"Chemotherapy-induced peripheral neurotoxicity (CIPN): An update","volume":"82","author":"Argyriou","year":"2012","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jpain.2016.10.020_bib6","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.lungcan.2012.05.094","article-title":"Prognostic factors for non\u2013small-cell lung cancer with bone metastasis at the time of diagnosis","volume":"77","author":"Bae","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jpain.2016.10.020_bib7","first-page":"112","article-title":"Skeletal implications of prostate cancer","volume":"3","author":"Bagi","year":"2003","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.jpain.2016.10.020_bib8","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/nrc3131","article-title":"Perineural invasion and associated pain in pancreatic cancer","volume":"11","author":"Bapat","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jpain.2016.10.020_bib9","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/2193-1801-3-366","article-title":"Chemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: A single-center experience","volume":"3","author":"Bhatnagar","year":"2014","journal-title":"Springerplus"},{"key":"10.1016\/j.jpain.2016.10.020_bib10","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ejca.2006.09.028","article-title":"Cisplatin-induced peripheral neuropathy: Neuroprotection by erythropoietin without affecting tumour growth","volume":"43","author":"Bianchi","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jpain.2016.10.020_bib11","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.2106\/JBJS.H.00175","article-title":"Surgical management of metastatic bone disease","volume":"91","author":"Bickels","year":"2009","journal-title":"J Bone Joint Surg"},{"key":"10.1016\/j.jpain.2016.10.020_bib12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.5114\/wo.2013.37214","article-title":"Bortezomib-induced painful neuropathy in patients with multiple myeloma","volume":"17","author":"Bilinska","year":"2013","journal-title":"Wspolczesna Onkologia"},{"key":"10.1016\/j.jpain.2016.10.020_bib13","first-page":"S12","article-title":"Chemotherapy induced peripheral neuropathy outcome measures standardisation (CI-PERINOMS) study","volume":"16","author":"Binda","year":"2011","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.jpain.2016.10.020_bib14","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jpainsymman.2012.11.003","article-title":"Living with advanced but stable multiple myeloma: A study of the symptom burden and cumulative effects of disease and intensive (hematopoietic stem cell transplant-based) treatment on health-related quality of life","volume":"46","author":"Boland","year":"2013","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpain.2016.10.020_bib15","doi-asserted-by":"crossref","first-page":"e2476","DOI":"10.1136\/bmj.e2476","article-title":"Pancreatic adenocarcinoma","volume":"344","author":"Bond-Smith","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.jpain.2016.10.020_bib16","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00280-012-2047-z","article-title":"Persistent chemoneuropathy in patients receiving the plant alkaloids paclitaxel and vincristine","volume":"71","author":"Boyette-Davis","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jpain.2016.10.020_bib17","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jpain.2011.04.008","article-title":"Follow-up psychophysical studies in bortezomib-related chemoneuropathy patients","volume":"12","author":"Boyette-Davis","year":"2011","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2016.10.020_bib18","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1158\/1078-0432.CCR-12-0205","article-title":"Subclinical peripheral neuropathy is a common finding in colorectal cancer patients prior to chemotherapy","volume":"18","author":"Boyette-Davis","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jpain.2016.10.020_bib19","first-page":"154","article-title":"Cancer-related neuropathic pain","volume":"9","author":"Brant","year":"1998","journal-title":"Nurse Pract Forum"},{"key":"10.1016\/j.jpain.2016.10.020_bib20","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/annonc\/mdp001","article-title":"Cancer-related pain: A pan-European survey of prevalence, treatment, and patient attitudes","volume":"20","author":"Breivik","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jpain.2016.10.020_bib21","doi-asserted-by":"crossref","first-page":"T118","DOI":"10.1016\/j.jpain.2015.10.014","article-title":"Approaches to demonstrating the reliability and validity of core diagnostic criteria for chronic pain","volume":"17","author":"Bruehl","year":"2016","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2016.10.020_bib22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/107327481201900210","article-title":"The management of pain in metastatic bone disease","volume":"19","author":"Buga","year":"2012","journal-title":"Cancer Control"},{"key":"10.1016\/j.jpain.2016.10.020_bib23","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1212\/WNL.0b013e31822cfc59","article-title":"Longitudinal assessment of oxaliplatin-induced neuropathy","volume":"77","author":"Burakgazi","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jpain.2016.10.020_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00256-005-0003-2","article-title":"Image-guided ablation of painful metastatic bone tumors: A new and effective approach to a difficult problem","volume":"35","author":"Callstrom","year":"2006","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.jpain.2016.10.020_bib25","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1034\/j.1399-6576.2001.450903.x","article-title":"Evaluation and assessment of cancer pain and cancer pain treatment","volume":"45","author":"Caraceni","year":"2001","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.jpain.2016.10.020_bib26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0304-3959(99)00073-1","article-title":"An international survey of cancer pain characteristics and syndromes","volume":"82","author":"Caraceni","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2016.10.020_bib27","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/(SICI)1097-0142(19960801)78:3<639::AID-CNCR45>3.0.CO;2-X","article-title":"Pain management in patients with pancreatic carcinoma","volume":"78","author":"Caraceni","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.jpain.2016.10.020_bib28","first-page":"1627","article-title":"Classification of cancer pain syndromes","volume":"15","author":"Caraceni","year":"2001","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.jpain.2016.10.020_bib29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3390\/jcm2030151","article-title":"Prevention and treatment of bone metastases in breast cancer","volume":"2","author":"Carla","year":"2013","journal-title":"J Clin Med"},{"key":"10.1016\/j.jpain.2016.10.020_bib30","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jpain.2006.09.014","article-title":"Quantitative sensory findings in patients with bortezomib-induced pain","volume":"8","author":"Cata","year":"2007","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2016.10.020_bib31","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S1470-2045(11)70131-0","article-title":"Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics","volume":"12","author":"Cavaletti","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jpain.2016.10.020_bib32","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1212\/01.WNL.0000092015.03923.19","article-title":"Grading of chemotherapy-induced peripheral neurotoxicity using the Total Neuropathy Scale","volume":"61","author":"Cavaletti","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jpain.2016.10.020_bib33","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/annonc\/mds329","article-title":"The chemotherapy-induced peripheral neuropathy outcome measures standardization study: From consensus to the first validity and reliability findings","volume":"24","author":"Cavaletti","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jpain.2016.10.020_bib34","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ejca.2009.12.008","article-title":"Chemotherapy-induced peripheral neurotoxicity assessment: A critical revision of the currently available tools","volume":"46","author":"Cavaletti","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jpain.2016.10.020_bib35","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1529-8027.2007.00141.x","article-title":"The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: Comparison with the National Cancer Institute-Common Toxicity Scale","volume":"12","author":"Cavaletti","year":"2007","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.jpain.2016.10.020_bib36","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3109\/10428194.2010.483303","article-title":"Peripheral neuropathy during bortezomib treatment of multiple myeloma: A review of recent studies","volume":"51","author":"Cavaletti","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jpain.2016.10.020_bib37","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nrneurol.2010.160","article-title":"Chemotherapy-induced peripheral neurotoxicity","volume":"6","author":"Cavaletti","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jpain.2016.10.020_bib38","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.lungcan.2014.08.022","article-title":"Bone metastasis, skeletal-related events, and mortality in lung cancer patients: A Danish population-based cohort study","volume":"86","author":"Cetin","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jpain.2016.10.020_bib39","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/j.pain.2014.08.026","article-title":"Exuberant sprouting of sensory and sympathetic nerve fibers in nonhealed bone fractures and the generation and maintenance of chronic skeletal pain","volume":"155","author":"Chartier","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2016.10.020_bib40","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1007\/s00520-012-1403-1","article-title":"Symptom clusters in patients with bone metastases - a reanalysis comparing different statistical methods","volume":"20","author":"Chen","year":"2012","journal-title":"Support Care Cancer"},{"issue":"415S","key":"10.1016\/j.jpain.2016.10.020_bib41","doi-asserted-by":"crossref","first-page":"S289","DOI":"10.1097\/01.blo.0000093054.96273.20","article-title":"Prospective quality of life research in bony metastatic disease","author":"Cheng","year":"2003","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.jpain.2016.10.020_bib42","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1089\/jpm.2006.9.850","article-title":"Mild, moderate, or severe pain categorized by patients with cancer with bone metastases","volume":"9","author":"Chow","year":"2006","journal-title":"J Palliat Med"},{"key":"10.1016\/j.jpain.2016.10.020_bib43","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00520-007-0241-z","article-title":"Symptom clusters in cancer patients with bone metastases","volume":"15","author":"Chow","year":"2007","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpain.2016.10.020_bib44","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3816\/SCT.2004.n.010","article-title":"Quality of life after local external beam radiation therapy for symptomatic bone metastases: A prospective evaluation","volume":"1","author":"Chow","year":"2004","journal-title":"Support Cancer Ther"},{"key":"10.1016\/j.jpain.2016.10.020_bib45","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/pon.1697","article-title":"Psychological distress in patients with pancreatic cancer\u2013an understudied group","volume":"19","author":"Clark","year":"2010","journal-title":"Psychooncology"},{"issue":"Suppl 2","key":"10.1016\/j.jpain.2016.10.020_bib46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1634\/theoncologist.2009-S501","article-title":"Assessment of cancer-related neuropathy and neuropathic pain","volume":"15","author":"Cleeland","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.jpain.2016.10.020_bib47","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1634\/theoncologist.11-3-227","article-title":"Too much, too little, too late to start again? Assessing the efficacy of bisphosphonates in patients with bone metastases from breast cancer","volume":"11","author":"Clemons","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.jpain.2016.10.020_bib48","doi-asserted-by":"crossref","first-page":"6243s","DOI":"10.1158\/1078-0432.CCR-06-0931","article-title":"Clinical features of metastatic bone disease and risk of skeletal morbidity","volume":"12","author":"Coleman","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jpain.2016.10.020_bib49","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","article-title":"Metastatic bone disease: Clinical features, pathophysiology and treatment strategies","volume":"27","author":"Coleman","year":"2001","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jpain.2016.10.020_bib50","first-page":"59","article-title":"Prostate cancer metastases to bone: Observational study for the evaluation of clinical presentation, course and treatment patterns. Presentation of the METAURO protocol and of patient baseline features","volume":"80","author":"Conti","year":"2008","journal-title":"Arch Ital Urol Androl"},{"key":"10.1016\/j.jpain.2016.10.020_bib51","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/jnci\/93.7.534","article-title":"Methodology for treatment evaluation in patients with cancer metastatic to bone","volume":"93","author":"Cook","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jpain.2016.10.020_bib52","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/1097-0142(19830815)52:4<610::AID-CNCR2820520406>3.0.CO;2-5","article-title":"Assessment of response of bone metastases to systemic treatment in patients with breast cancer","volume":"52","author":"Coombes","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.jpain.2016.10.020_bib53","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.1158\/0008-5472.CAN-14-2060","article-title":"A quantitative sensory analysis of peripheral neuropathy in colorectal cancer and its exacerbation by oxaliplatin chemotherapy","volume":"74","author":"de Carvalho Barbosa","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.jpain.2016.10.020_bib54","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/bja\/aen100","article-title":"Translational medicine: Cancer pain mechanisms and management","volume":"101","author":"Delaney","year":"2008","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jpain.2016.10.020_bib55","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrgastro.2015.166","article-title":"Neural plasticity in pancreatitis and pancreatic cancer","volume":"12","author":"Demir","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jpain.2016.10.020_bib56","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1210\/jc.2014-4250","article-title":"PTHrP-mediated hypercalcemia: Causes and survival in 138 patients","volume":"100","author":"Donovan","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpain.2016.10.020_bib57","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jpainsymman.2006.08.006","article-title":"Dysfunction in multiple primary afferent fiber subtypes revealed by quantitative sensory testing in patients with chronic vincristine-induced pain","volume":"33","author":"Dougherty","year":"2007","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpain.2016.10.020_bib58","first-page":"6","article-title":"Bone metastasis \u2013 an overview","volume":"8","author":"Dubey","year":"2010","journal-title":"Internet J Pain, Symptom Contr Palliat Care"},{"key":"10.1016\/j.jpain.2016.10.020_bib59","doi-asserted-by":"crossref","first-page":"T1","DOI":"10.1016\/j.jpain.2016.02.010","article-title":"Multidimensional diagnostic criteria for chronic pain: Introduction to the ACTTION-American Pain Society Pain Taxonomy (AAPT)","volume":"17","author":"Dworkin","year":"2016","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2016.10.020_bib60","doi-asserted-by":"crossref","first-page":"T70","DOI":"10.1016\/j.jpain.2016.01.001","article-title":"The role of psychosocial processes in the development and maintenance of chronic pain","volume":"17","author":"Edwards","year":"2016","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2016.10.020_bib61","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1200\/JCO.2013.51.7219","article-title":"Pain and nociception: Mechanisms of cancer-induced bone pain","volume":"32","author":"Falk","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpain.2016.10.020_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/SPC.0b013e328342f9cc","article-title":"Chemotherapy-induced neuropathic pain","volume":"5","author":"Farquhar-Smith","year":"2011","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.jpain.2016.10.020_bib63","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.12968\/bjon.2013.22.Sup7.S4","article-title":"Bone metastases: Assessment, management and treatment options","volume":"22","author":"Farrell","year":"2013","journal-title":"Br J Nurs"},{"key":"10.1016\/j.jpain.2016.10.020_bib64","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.gtc.2007.03.011","article-title":"Pain in chronic pancreatitis and pancreatic cancer","volume":"36","author":"Fasanella","year":"2007","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jpain.2016.10.020_bib65","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jpain.2014.01.004","article-title":"The ACTTION-American Pain Society Pain Taxonomy (AAPT): An evidence-based and multidimensional approach to classifying chronic pain conditions","volume":"15","author":"Fillingim","year":"2014","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2016.10.020_bib66","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/bs.pmbts.2014.12.004","article-title":"The contribution of mitochondria to sensory processing and pain","volume":"131","author":"Flatters","year":"2015","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.jpain.2016.10.020_bib67","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.pain.2013.10.023","article-title":"Sensory profiles of patients with neuropathic pain based on the neuropathic pain symptoms and signs","volume":"155","author":"Freeman","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2016.10.020_bib68","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.pain.2013.08.028","article-title":"Pain in chemotherapy-induced neuropathy\u2013more than neuropathic?","volume":"154","author":"Geber","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2016.10.020_bib69","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1533-2500.2012.00554.x","article-title":"Chemotherapy-induced neuropathic pain and its relation to cluster symptoms in breast cancer patients treated with paclitaxel","volume":"13","author":"Golan-Vered","year":"2013","journal-title":"Pain Pract"},{"key":"10.1016\/j.jpain.2016.10.020_bib70","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/SPC.0b013e328133f5e9","article-title":"Central neuronal mechanisms in cancer-induced bone pain","volume":"1","author":"Gordon-Williams","year":"2007","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.jpain.2016.10.020_bib71","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/SPC.0000000000000043","article-title":"Nonsurgical oncological management of cancer pain","volume":"8","author":"Gough","year":"2014","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.jpain.2016.10.020_bib72","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jpainsymman.2007.01.001","article-title":"Managing metastatic bone pain: The role of bisphosphonates","volume":"33","author":"Gralow","year":"2007","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpain.2016.10.020_bib73","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0733-8619(18)30251-2","article-title":"Metastatic epidural spinal cord compression","volume":"9","author":"Grant","year":"1991","journal-title":"Neurol Clin"},{"key":"10.1016\/j.jpain.2016.10.020_bib74","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jpain.2015.06.008","article-title":"Pharmacological modulation of the mitochondrial electron transport chain in paclitaxel-induced painful peripheral neuropathy","volume":"16","author":"Griffiths","year":"2015","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2016.10.020_bib75","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0030-5898(05)70171-1","article-title":"Incidence, location, and diagnostic evaluation of metastatic bone disease","volume":"31","author":"Hage","year":"2000","journal-title":"Orthop Clin North Am"},{"key":"10.1016\/j.jpain.2016.10.020_bib76","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1200\/JCO.2007.15.0367","article-title":"Pain predicts overall survival in men with metastatic castration-refractory prostate cancer","volume":"26","author":"Halabi","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpain.2016.10.020_bib77","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fphar.2013.00156","article-title":"Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN)","volume":"4","author":"Han","year":"2013","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jpain.2016.10.020_bib78","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/j.seminoncol.2005.12.010","article-title":"Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy","volume":"33","author":"Hausheer","year":"2006","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jpain.2016.10.020_bib79","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/01376517-200312000-00006","article-title":"Pharmacologic management of cancer pain","volume":"35","author":"Herdon","year":"2003","journal-title":"J Neurosci Nurs"},{"key":"10.1016\/j.jpain.2016.10.020_bib80","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2013.54.0914","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"32","author":"Hershman","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpain.2016.10.020_bib81","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1200\/JCO.2015.66.2346","article-title":"Comorbidities and risk of chemotherapy-induced peripheral neuropathy among participants 65 years or older in Southwest Oncology Group clinical trials","volume":"34","author":"Hershman","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpain.2016.10.020_bib82","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/annonc\/mdt018","article-title":"CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel","volume":"24","author":"Hertz","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jpain.2016.10.020_bib83","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3747\/co.21.1984","article-title":"The influence of chemotherapy-induced neurotoxicity on psychological distress and sleep disturbance in cancer patients","volume":"21","author":"Hong","year":"2014","journal-title":"Curr Oncol"},{"key":"10.1016\/j.jpain.2016.10.020_bib84","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1200\/JCO.2014.59.4895","article-title":"Osteosarcoma: Current treatment and a collaborative pathway to success","volume":"33","author":"Isakoff","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpain.2016.10.020_bib85","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0885-3924(98)00069-4","article-title":"Presenting symptoms in patients referred to a multidisciplinary clinic for bone metastases","volume":"16","author":"Janjan","year":"1998","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpain.2016.10.020_bib86","doi-asserted-by":"crossref","first-page":"177","DOI":"10.12954\/PI.13027","article-title":"Anxiety level of early- and late-stage prostate cancer patients","volume":"1","author":"Johanes","year":"2013","journal-title":"Prostate Int"},{"key":"10.1016\/j.jpain.2016.10.020_bib87","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1742-1241.2003.tb10461.x","article-title":"Bone metastasis as the first manifestation of lung cancer","volume":"57","author":"Kagohashi","year":"2003","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jpain.2016.10.020_bib88","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jpainsymman.2007.12.014","article-title":"Has pain management in cancer patients with bone metastases improved? A seven-year review at an outpatient palliative radiotherapy clinic","volume":"37","author":"Kirou-Mauro","year":"2009","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpain.2016.10.020_bib89","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1158\/0008-5472.CAN-03-3823","article-title":"Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds","volume":"64","author":"Klein","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.jpain.2016.10.020_bib90","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/0885-3924(91)90027-2","article-title":"Symptoms of pancreatic cancer","volume":"6","author":"Krech","year":"1991","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpain.2016.10.020_bib91","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s12149-012-0598-z","article-title":"EORTC QLQ-BM22 and QLQ-C30 quality of life scores in patients with painful bone metastases of prostate cancer treated with strontium-89 radionuclide therapy","volume":"26","author":"Kurosaka","year":"2012","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.jpain.2016.10.020_bib92","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s00520-010-0961-3","article-title":"Characterization of cancer-induced bone pain: An exploratory study","volume":"19","author":"Laird","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpain.2016.10.020_bib93","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/j.pain.0000000000000130","article-title":"TMPRSS2, a novel membrane-anchored mediator in cancer pain","volume":"156","author":"Lam","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2016.10.020_bib94","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1007\/s00259-004-1539-4","article-title":"186Re-HEDP for metastatic bone pain in breast cancer patients","volume":"31","author":"Lam","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jpain.2016.10.020_bib95","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jpain.2010.10.015","article-title":"Trajectories of pain and analgesics in oncology outpatients with metastatic bone pain","volume":"12","author":"Langford","year":"2011","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2016.10.020_bib96","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jpainsymman.2014.11.300","article-title":"Neuropathic symptoms and their risk factors in medical oncology outpatients with colorectal vs. breast, lung, or prostate cancer: Results from a prospective multicenter study","volume":"49","author":"Lewis","year":"2015","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpain.2016.10.020_bib97","doi-asserted-by":"crossref","first-page":"13487","DOI":"10.1523\/JNEUROSCI.1956-15.2015","article-title":"The cancer chemotherapeutic paclitaxel increases human and rodent sensory neuron responses to TRPV1 by activation of TLR4","volume":"35","author":"Li","year":"2015","journal-title":"J Neurosci"},{"key":"10.1016\/j.jpain.2016.10.020_bib98","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.bbi.2015.06.003","article-title":"MAPK signaling downstream to TLR4 contributes to paclitaxel-induced peripheral neuropathy","volume":"49","author":"Li","year":"2015","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jpain.2016.10.020_bib99","doi-asserted-by":"crossref","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration","volume":"151","author":"Liberati","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jpain.2016.10.020_bib100","doi-asserted-by":"crossref","first-page":"T93","DOI":"10.1016\/j.jpain.2016.06.002","article-title":"Overlapping chronic pain conditions: Implications for diagnosis and classification","volume":"17","author":"Maixner","year":"2016","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2016.10.020_bib101","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11910-008-0010-5","article-title":"Chemotherapy-induced peripheral neuropathy","volume":"8","author":"Malik","year":"2008","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"Suppl 1","key":"10.1016\/j.jpain.2016.10.020_bib102","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/j.pain.2013.07.044","article-title":"Bone cancer pain: Causes, consequences, and therapeutic opportunities","volume":"154","author":"Mantyh","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2016.10.020_bib103","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/SPC.0000000000000048","article-title":"Bone cancer pain: From mechanism to therapy","volume":"8","author":"Mantyh","year":"2014","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.jpain.2016.10.020_bib104","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s12630-014-0171-4","article-title":"Brief review: Chemotherapy-induced painful peripheral neuropathy (CIPPN): Current status and future directions","volume":"61","author":"Massey","year":"2014","journal-title":"Can J Anesth"},{"key":"10.1016\/j.jpain.2016.10.020_bib105","doi-asserted-by":"crossref","first-page":"7014","DOI":"10.1158\/0008-5472.CAN-14-1220","article-title":"NGF blockade at early times during bone cancer development attenuates bone destruction and increases limb use","volume":"74","author":"McCaffrey","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.jpain.2016.10.020_bib106","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jpain.2012.03.003","article-title":"Changes in pain and other symptoms in patients with painful multiple myeloma-related vertebral fracture treated with kyphoplasty or vertebroplasty","volume":"13","author":"Mendoza","year":"2012","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2016.10.020_bib107","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.jpainsymman.2003.04.004","article-title":"Celiac plexus block for pancreatic cancer pain: Factors influencing pain, symptoms and quality of life","volume":"26","author":"Mercadante","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpain.2016.10.020_bib108","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1002\/cncr.28699","article-title":"Disease and treatment characteristics do not predict symptom occurrence profiles in oncology outpatients receiving chemotherapy","volume":"120","author":"Miaskowski","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.jpain.2016.10.020_bib109","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1185\/03007995.2014.907562","article-title":"Is an easy and reliable diagnosis of localized neuropathic pain (LNP) possible in general practice? Development of a screening tool based on IASP criteria","volume":"30","author":"Mick","year":"2014","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jpain.2016.10.020_bib110","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1470-2045(11)70328-X","article-title":"Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2-3 years of tamoxifen: A retrospective analysis of the Intergroup Exemestane Study","volume":"13","author":"Mieog","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jpain.2016.10.020_bib111","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ctrv.2014.04.004","article-title":"Chemotherapy-induced neuropathy: A comprehensive survey","volume":"40","author":"Miltenburg","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jpain.2016.10.020_bib112","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jpainsymman.2009.07.005","article-title":"Retrospective assessment of cancer pain management in an outpatient palliative radiotherapy clinic using the Pain Management Index","volume":"39","author":"Mitera","year":"2010","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpain.2016.10.020_bib113","first-page":"565","article-title":"A characterization study of breakthrough pain in cancer induced bone pain","volume":"26","author":"Montgomery","year":"2012","journal-title":"Palliat Medicine"},{"key":"10.1016\/j.jpain.2016.10.020_bib114","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1470-2045(11)70081-X","article-title":"Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: A randomised, phase 3, non-inferiority study","volume":"12","author":"Moreau","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jpain.2016.10.020_bib115","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.pain.2013.11.010","article-title":"Confirming neuropathic pain in cancer patients: Applying the NeuPSIG grading system in clinical practice and clinical research","volume":"155","author":"Mulvey","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2016.10.020_bib116","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jpainsymman.2010.10.268","article-title":"Pronociceptive pain modulation in patients with painful chemotherapy-induced polyneuropathy","volume":"42","author":"Nahman-Averbuch","year":"2011","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpain.2016.10.020_bib117","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cryobiol.2012.12.002","article-title":"Alleviating visceral cancer pain in patients with pancreatic cancer using cryoablation and celiac plexus block","volume":"66","author":"Niu","year":"2013","journal-title":"Cryobiology"},{"key":"10.1016\/j.jpain.2016.10.020_bib118","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/AJP.0b013e3181b0c82c","article-title":"Time course of pain relief in patients treated with radiotherapy for cancer pain: A prospective study","volume":"26","author":"Nomiya","year":"2010","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jpain.2016.10.020_bib119","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1200\/JCO.2015.62.1276","article-title":"Cerebral perfusion and gray matter changes associated with chemotherapy-induced peripheral neuropathy","volume":"34","author":"Nudelman","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpain.2016.10.020_bib120","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1007\/s00520-014-2289-x","article-title":"Management options for established chemotherapy-induced peripheral neuropathy","volume":"22","author":"Pachman","year":"2014","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpain.2016.10.020_bib121","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.pain.2010.10.010","article-title":"Chronic treatment-related pain in cancer survivors","volume":"152","author":"Paice","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2016.10.020_bib122","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3322\/caac.21204","article-title":"Chemotherapy-induced peripheral neurotoxicity: A critical analysis","volume":"63","author":"Park","year":"2013","journal-title":"Ca Cancer J Clin"},{"key":"10.1016\/j.jpain.2016.10.020_bib123","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/104990919801500108","article-title":"Managing the pain of bone metastases in the home environment","volume":"15","author":"Phillips","year":"1998","journal-title":"Am J Hosp Palliat Med"},{"key":"10.1016\/j.jpain.2016.10.020_bib124","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/01893697-201028020-00002","article-title":"Chemotherapy induced peripheral neuropathy: Risk factors, pathophysiology, assessment, and potential physical therapy interventions","volume":"28","author":"Pignataro","year":"2010","journal-title":"Rehabil Oncol"},{"key":"10.1016\/j.jpain.2016.10.020_bib125","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0090-4295(79)90280-2","article-title":"Bone pain in metastatic cancer of prostate","volume":"13","author":"Pollen","year":"1979","journal-title":"Urology"},{"key":"10.1016\/j.jpain.2016.10.020_bib126","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1016\/S0140-6736(11)60236-5","article-title":"Treatment of cancer pain","volume":"377","author":"Portenoy","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jpain.2016.10.020_bib127","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0304-3959(90)90004-W","article-title":"Breakthrough pain: Definition, prevalence and characteristics","volume":"41","author":"Portenoy","year":"1990","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2016.10.020_bib128","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.clcc.2015.07.001","article-title":"Quantitative sensory testing at baseline and during cycle 1 oxaliplatin infusion detects subclinical peripheral neuropathy and predicts clinically overt chronic neuropathy in gastrointestinal malignancies","volume":"15","author":"Reddy","year":"2016","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.jpain.2016.10.020_bib129","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jpain.2014.07.003","article-title":"Survival patterns in squamous cell carcinoma of the head and neck: Pain as an independent prognostic factor for survival","volume":"15","author":"Reyes-Gibby","year":"2014","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2016.10.020_bib130","first-page":"1489","article-title":"Metastatic carcinoma of the long bones","volume":"76","author":"Riccio","year":"2007","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jpain.2016.10.020_bib131","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.6004\/jnccn.2010.0115","article-title":"Complications of multiple myeloma therapy, part 1: Risk reduction and management of peripheral neuropathy and asthenia","volume":"8","author":"Richardson","year":"2010","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jpain.2016.10.020_bib132","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1007\/s00198-013-2530-3","article-title":"Cancer-associated bone disease","volume":"24","author":"Rizzoli","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jpain.2016.10.020_bib133","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.breast.2011.08.086","article-title":"Clinical symptoms of bone marrow metastases in breast cancer patients","volume":"20","author":"Rodionov","year":"2011","journal-title":"Breast"},{"key":"10.1016\/j.jpain.2016.10.020_bib134","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jpainsymman.2005.04.002","article-title":"Predictors of quality of life in oncology outpatients with pain from bone metastasis","volume":"30","author":"Rustoen","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpain.2016.10.020_bib135","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00000542-200002000-00014","article-title":"Efficacy of neurolytic celiac plexus block in varying locations of pancreatic cancer: Influence on pain relief","volume":"92","author":"Rykowski","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jpain.2016.10.020_bib136","first-page":"317","article-title":"Bone metastasis of primary lung cancer [in Japanese]","volume":"36","author":"Ryo","year":"1998","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"10.1016\/j.jpain.2016.10.020_bib137","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1470-2045(07)70033-5","article-title":"Part II: Spinal-cord neoplasms\u2013primary tumours of the bony spine and adjacent soft tissues","volume":"8","author":"Sansur","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jpain.2016.10.020_bib138","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1016\/j.joms.2015.04.045","article-title":"The neurobiology of cancer pain","volume":"73","author":"Schmidt","year":"2015","journal-title":"J Oral Maxillofac Surg"},{"issue":"Suppl 1","key":"10.1016\/j.jpain.2016.10.020_bib139","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1097\/j.pain.0000000000000099","article-title":"What pain tells us about cancer","volume":"156","author":"Schmidt","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2016.10.020_bib140","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejpain.2011.05.002","article-title":"Quantitative sensory testing to assess the sensory characteristics of cancer-induced bone pain after radiotherapy and potential clinical biomarkers of response","volume":"16","author":"Scott","year":"2012","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jpain.2016.10.020_bib141","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","article-title":"Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis","volume":"155","author":"Seretny","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2016.10.020_bib142","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1200\/JCO.2009.22.0236","article-title":"Aromatase inhibitor-induced carpal tunnel syndrome: Results from the ATAC trial","volume":"27","author":"Sestak","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpain.2016.10.020_bib143","series-title":"Practical Management of Complex Cancer Pain","author":"Sharma","year":"2014"},{"key":"10.1016\/j.jpain.2016.10.020_bib144","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"Ca Cancer J Clin"},{"key":"10.1016\/j.jpain.2016.10.020_bib145","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1038\/sj.bjc.6690607","article-title":"Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer","volume":"80","author":"Silverman","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jpain.2016.10.020_bib146","first-page":"47","article-title":"Use of animal models in understanding cancer-induced bone pain","volume":"8","author":"Slosky","year":"2015","journal-title":"Cancer Growth Metastasis"},{"key":"10.1016\/j.jpain.2016.10.020_bib147","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1002\/cncr.27463","article-title":"A prospective surveillance model for physical rehabilitation of women with breast cancer: Chemotherapy-induced peripheral neuropathy","volume":"118","author":"Stubblefield","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.jpain.2016.10.020_bib148","doi-asserted-by":"crossref","first-page":"442","DOI":"10.12968\/ijpn.2014.20.9.442","article-title":"Neuropathic pain in people with cancer (part 1): Incidence, manifestation, and assessment","volume":"20","author":"Taverner","year":"2014","journal-title":"Int J Palliat Nurs"},{"key":"10.1016\/j.jpain.2016.10.020_bib149","first-page":"738","article-title":"Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer","volume":"7","author":"Tersmette","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jpain.2016.10.020_bib150","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/j.pain.0000000000000491","article-title":"The pain in neuropathy study (PiNS): A cross-sectional observational study determining the somatosensory phenotype of painful and painless diabetic neuropathy","volume":"157","author":"Themistocleous","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2016.10.020_bib151","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1188\/13.CJON.138-144","article-title":"Chemotherapy-induced peripheral neuropathy","volume":"17","author":"Tofthagen","year":"2013","journal-title":"Clin J Oncol Nurs"},{"key":"10.1016\/j.jpain.2016.10.020_bib152","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/01.anes.0000435634.34709.65","article-title":"Characterization of acute and chronic neuropathies induced by oxaliplatin in mice and differential effects of a novel mitochondria-targeted antioxidant on the neuropathies","volume":"120","author":"Toyama","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jpain.2016.10.020_bib153","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1097\/j.pain.0000000000000160","article-title":"A classification of chronic pain for ICD-11","volume":"156","author":"Treede","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2016.10.020_bib154","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00520-009-0645-z","article-title":"Skeletal-related events (SREs) in breast cancer patients with bone metastases treated in the nontrial setting","volume":"18","author":"Trinkaus","year":"2010","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpain.2016.10.020_bib155","doi-asserted-by":"crossref","first-page":"T21","DOI":"10.1016\/j.jpain.2016.02.006","article-title":"Assessment of psychosocial and functional impact of chronic pain","volume":"17","author":"Turk","year":"2016","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2016.10.020_bib156","doi-asserted-by":"crossref","first-page":"T50","DOI":"10.1016\/j.jpain.2016.03.001","article-title":"Towards a mechanism based pain diagnosis","volume":"17","author":"Vardeh","year":"2016","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2016.10.020_bib157","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/j.pain.0000000000000404","article-title":"Chemotherapy-induced pain and neuropathy: A prospective study in patients treated with adjuvant oxaliplatin or docetaxel","volume":"157","author":"Ventzel","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2016.10.020_bib158","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s00280-013-2152-7","article-title":"Subclinical pretreatment sensory deficits appear to predict the development of pain and numbness in patients with multiple myeloma undergoing chemotherapy","volume":"71","author":"Vichaya","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jpain.2016.10.020_bib159","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1155\/2009\/251239","article-title":"Prevalence and correlates of pain in the Canadian National Palliative Care Survey","volume":"14","author":"Wilson","year":"2009","journal-title":"Pain Res Manag"},{"key":"10.1016\/j.jpain.2016.10.020_bib160","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1007\/s00520-013-1731-9","article-title":"Minimal clinically important differences in the brief pain inventory in patients with bone metastases","volume":"21","author":"Wong","year":"2013","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpain.2016.10.020_bib161","doi-asserted-by":"crossref","first-page":"e89583","DOI":"10.1371\/journal.pone.0089583","article-title":"Spinal changes of a newly isolated neuropeptide endomorphin-2 concomitant with vincristine-induced allodynia","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jpain.2016.10.020_bib162","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/bcpt.12262","article-title":"Chemotherapy-induced polyneuropathy: Major agents and assessment by questionnaires","volume":"115","author":"Zedan","year":"2014","journal-title":"Basic Clin Pharmacol Toxicol"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590016303121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590016303121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T23:20:27Z","timestamp":1694906427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590016303121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":162,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1526590016303121"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2016.10.020","relation":{},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AAPT Diagnostic Criteria for Chronic Cancer Pain Conditions","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2016.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Inc. on behalf of the American Pain Society.","name":"copyright","label":"Copyright"}]}}